How Alpha Linolenic Acid May Sustain Blood–Brain Barrier Integrity and Boost Brain Resilience against Alzheimer’s Disease

Cognitive decline, the primary clinical phenotype of Alzheimer’s disease (AD), is currently attributed mainly to amyloid and tau protein deposits. However, a growing body of evidence is converging on brain lipids, and blood–brain barrier (BBB) dysfunction, as crucial players involved in AD developme...

Descripción completa

Detalles Bibliográficos
Autores principales: Leikin-Frenkel, Alicia, Schnaider Beeri, Michal, Cooper, Itzik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737216/
https://www.ncbi.nlm.nih.gov/pubmed/36501121
http://dx.doi.org/10.3390/nu14235091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737216/
https://www.ncbi.nlm.nih.gov/pubmed/36501121
http://dx.doi.org/10.3390/nu14235091

Ejemplares similares